On September 28, 2022, Shiseido Europe S.A., a subsidiary of Shiseido Company, Limited, entered into an agreement to acquire all of the outstanding shares of Gallinée Ltd ("Gallinée"), a London-based beauty brand dedicated to the care of the skin microbiome from head to toe. The acquisition of Gallinée illustrates Shiseido's commitment to the skin beauty category, helping us achieve our mission of integrating skin beauty and inner beauty, while continuing to position ourselves to "be a global winner with our heritage." This commitment is part of our 'Win 2023 and Beyond' strategy, which aims to become the first global company in the category by 2030.
Gallinée was founded in 2014 by Marie Drago, PharmD, a world-renowned specialist in the skin microbiome. The skin microbiome plays a vital role in our skin and overall health by protecting us from the outside world. The brand offers a range of science-backed beauty products, featuring a patented complex of prebiotics, probiotics and postbiotics that nourish and strengthen the skin's microbiome. Gallinée will bring a unique complement to Shiseido's existing portfolio, given its focus on beauty and well-being, as well as its differentiated positioning in the emerging field of the skin microbiome. As a member of the Shiseido Group, Gallinée will be able to leverage the resources of our commercial infrastructure, extensive R&D capabilities, in particular our European Innovation Center, to lead the development of the skin microbiome in EMEA, and cross-functional expertise to continue driving brand growth.
Following the transaction, Marie Drago, PharmD, will join Shiseido's Emea team and continue to provide product innovation and support Gallinée as chief creative officer of the brand, reporting directly to Franck Marilly, President & CEO, Shiseido Emea & Global Fragrance.